Ligand density at the surface of a nanoparticle and different uptake mechanism: Two important factors for successful siRNA delivery to liver endothelial cells-Reference-Cited by-同舟云学术

Ligand density at the surface of a nanoparticle and different uptake mechanism: Two important factors for successful siRNA delivery to liver endothelial cells

Published:2014-11 Issue:1-2 Volume:475 Page:227-237
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Akhter Afsana,Hayashi Yasuhiro,Sakurai Yu,Ohga Noritaka,Hida Kyoko,Harashima Hideyoshi

Funder

Special Education and Research Expenses of the Ministry of Education, Culture, Sports, Science and Technology of Japan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference30 articles.

1. A liposomal delivery system that targets liver endothelial cells based on a new peptide motif present in the ApoB-100 sequence;Akhter;Int. J. Pharm.,2013

2. Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors;Akino;Am. J. Pathol.,2009

3. Stabilized lipid coated lipoplexes for the delivery of antisense oligonucleotides to liver endothelial cells in vitro and in vivo;Bartsch;J. Drug Target.,2004

4. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli;Berry;Infect. Immun.,2009

5. Upregulation of the coagulation factor VII gene during glucose deprivation is mediated by activating transcription factor 4;Cronin;PLoS One,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Applications of PLGA Hydrogels for Sustained Delivery of Therapeutic Agents;Gels;2024-07-26

2. Advancing Bone-Targeted Drug Delivery: Leveraging Biological Factors and Nanoparticle Designs to Improve Therapeutic Efficacy;ACS Biomaterials Science & Engineering;2024-03-27

3. Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance;Nanomaterials;2023-12-26

4. Current, emerging, and potential therapies for non-alcoholic steatohepatitis;Frontiers in Pharmacology;2023-03-30

5. Polymeric nanomedicines for the treatment of hepatic diseases;Journal of Nanobiotechnology;2022-11-19